Eur J Endocrinol
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


DOI: 10.1530/EJE-08-0964
European Journal of Endocrinology, Vol 161, Issue 1, 43-50
Copyright © 2009 by European Society of Endocrinology
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
EJE-08-0964v1
161/1/43    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Edouard, T
Right arrow Articles by Tauber, M
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Edouard, T
Right arrow Articles by Tauber, M

CLINICAL STUDY

Prevalence of IGF1 deficiency in prepubertal children with isolated short stature

T Edouard1,4, S Grünenwald2, I Gennero3,4, J P Salles1,4 and M Tauber1,4

1 Department of Paediatric Endocrinology, Hôpital des Enfants, Toulouse, France2 Department of Endocrinology, Hôpital Larrey, Toulouse, France3 , Department of Biology4 INSERM U563, Department of Lipoprotéines et Médiateurs Lipidiques, Hôpital Purpan, Toulouse, France

(Correspondence should be addressed to M Tauber; Email: tauber.mt{at}chu-toulouse.fr)

Background/aims: ‘Primary IGF1 deficiency (IGFD)’ is defined by low levels of IGF1 without a concomitant impairment in GH secretion in the absence of secondary cause. The aims of this study were to evaluate the prevalence of non-GH deficient IGFD in prepubertal children with isolated short stature (SS) and to describe this population.

Methods: This retrospective study included all children with isolated SS seen in our Pediatric Endocrinology Unit from January 2005 to December 2007. Children were included based on the following criteria: i) SS with current height SDS ≤ –2.5, ii) age≥2 years, and iii) prepubertal status. Exclusion criteria were: i) identified cause of SS and ii) current or past therapy with rhGH. IGF1-deficient children were defined as children without GH deficiency and with IGF1 levels below or equal to –2 SDS.

Results: Among 65 children with isolated SS, 13 (20%) had low IGF1 levels, consistent with a diagnosis of primary IGFD, four of which were born small for gestational age and nine were born appropriate for gestational age. When compared with non-IGFD children, IGFD children had higher birth weight (–0.7 vs –1 SDS, P=0.02) and birth height (–1.7 vs –2 SDS, P=0.04) and more delayed bone age (2.6 vs 1.7 years, P=0.03).

Conclusion: The prevalence of primary IGFD was 20% in children with isolated SS. Concerning the pathophysiology, our study emphasizes that IGFD in some children may be secondary to nutritional deficiency or to maturational delay.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2009 European Society of Endocrinology.